课题基金 / 基金详情

项目摘要

项目成果

A.M. Rostami的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pro-inflammatory cytokine essential for the development and progression of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Although GM-CSF is mainly produced by pathogenic Th17 and Th1 cells, GM-CSF receptor (GM-CSFR) is not expressed on T and B cells, but is expressed on antigen-presenting cells (APCs). Among them, Ly6ChiCCR2+ monocytes are essential for the pathogenic role of GM-CSF in EAE. Further, GM- CSF signaling in peripheral, but not CNS cells, plays a vital role in the development of acute EAE. However, whether lack of GM-CSF signaling results in development of immunoregulatory APCs has not been studied, and the role of GM-CSF signaling in CNS cells in EAE chronicity, for which microglia activation plays a major role, remains unknown. Our preliminary results for the first time show enhanced production of immunoregulatory molecules in APCs, and increased IL-10 and Foxp3 expression in CD4+ T cells of mice lacking GM-CSF. Similarly, neutralizing GM-CSF in human monocyte culture results in an increase of IL-27 and TGF-β production. Based on these observations, we hypothesize that GM-CSF induces proinflammatory monocytes, whereas its blockade results in the induction of immunoregulatory APCs and suppression of EAE. We will test this hypothesis in the following specific aims: 1) To determine the impact of GM-CSF on phenotype of APCs and T cells in EAE. We will test the hypothesis that blockade of GM-CSF signaling in monocytes leads to the development of immunoregulatory APCs that promote development of Tr1/Treg cells, resulting in suppression of EAE. 2) To investigate the effect of GM-CSF on the phenotype of microglia/macrophages in chronic phase of EAE. We will test our hypothesis that GM-CSF promotes activation and pro-inflammatory M1 phenotype of macrophages/microglia in chronic phase of EAE, which contributes to disease chronicity. 3) To determine the effects of blocking GM-CSF on phenotype and function of human monocytes. We will test the hypothesis that GM-CSF promotes development of a proinflammatory phenotype of human monocytes. These studies should fill the gap in our knowledge on mechanisms of proinflammatory action of GM- CSF and its relevant cellular targets in EAE/MS, with potential therapeutic effect in certain autoimmune diseases.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity.
氯喹处理的树突状细胞需要STAT1信号传导其耐受性活性。
DOI: 10.1002/eji.201747362
发表时间: 2018-07
期刊: European journal of immunology
影响因子: 5.4
作者: [Thome R, Bonfanti AP, Rasouli J, Mari ER, Zhang GX, Rostami A, Verinaud L]
通讯作者: Verinaud L
IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
IL-9 通过抑制 GM-CSF 产生来控制中枢神经系统自身免疫。
DOI: 10.4049/jimmunol.1801113
发表时间: 2020
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Yoshimura,Satoshi, Thome,Rodolfo, Konno,Shingo, Mari,ElisabethR, Rasouli,Javad, Hwang,Daniel, Boehm,Alexandra, Li,Yanhua, Zhang,Guang-Xian, Ciric,Bogoljub, Rostami,Abdolmohamad]
通讯作者: Rostami,Abdolmohamad
DOI: 10.1126/scitranslmed.aba0599
发表时间: 2020-11-04
期刊: Science translational medicine
影响因子: 17.1
作者: [Casella G, Rasouli J, Boehm A, Zhang W, Xiao D, Ishikawa LLW, Thome R, Li X, Hwang D, Porazzi P, Molugu S, Tang HY, Zhang GX, Ciric B, Rostami A]
通讯作者: Rostami A
DOI: 10.1016/j.jneuroim.2017.12.017
发表时间: 2018-04-15
期刊: Journal of neuroimmunology
影响因子: 3.3
作者: [Imitola J, Rasouli J, Watanabe F, Mahajan K, Sharan AD, Ciric B, Zhang GX, Rostami A]
通讯作者: Rostami A
ThGM Cells in CNS Autoimmunity
  • 批准号:
    10449359
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2021
  • 负责人:
    A.M. Rostami
  • 依托单位:
IL-37: a novel regulator of inflammation in CNS autoimmunity
  • 批准号:
    10199564
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2021
  • 负责人:
    A.M. Rostami
  • 依托单位:
ThGM Cells in CNS Autoimmunity
  • 批准号:
    10299105
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2021
  • 负责人:
    A.M. Rostami
  • 依托单位:
IL-37: a novel regulator of inflammation in CNS autoimmunity
  • 批准号:
    10369694
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2021
  • 负责人:
    A.M. Rostami
  • 依托单位:
海外基金